| |
| |
|
| Insider
Information: |
Sherman Jeffrey W |
| Relationship: |
Director |
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP and Chief Medical ... |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
Strongbridge Biopharma Plc |
SBBP |
Director |
2021-10-05 |
0 |
2019-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
98 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2023-01-10 |
4 |
AS |
$113.05 |
$380,752 |
D/D |
(3,368) |
39,539 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2021-05-14 |
4 |
D |
$2.35 |
$44,518 |
D/D |
(18,944) |
42,021 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-03-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,169 |
44,107 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-06-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,287 |
44,775 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,304 |
46,989 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2020-05-11 |
4 |
OE |
$4.96 |
$166,056 |
D/D |
33,479 |
47,445 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-05-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,304 |
50,062 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-06-11 |
4 |
GA |
$0.00 |
$0 |
D/D |
5,287 |
52,276 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-03-18 |
4 |
OE |
$22.14 |
$188,876 |
D/D |
8,531 |
52,638 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-03-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,169 |
52,944 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Medical Officer |
• – – |
2013-01-02 |
4 |
S |
$2.36 |
$38,477 |
D/D |
(16,304) |
55,099 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-09-21 |
4 |
OE |
$7.61 |
$352,122 |
D/D |
46,271 |
55,386 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,675) |
56,311 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-01-21 |
4 |
D |
$86.42 |
$204,988 |
D/D |
(2,372) |
59,293 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2020-05-15 |
4 |
D |
$2.86 |
$54,440 |
D/D |
(19,035) |
60,965 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Medical Officer |
• – – |
2012-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
61,105 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-05-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,531 |
61,475 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,354 |
61,665 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2022-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,570 |
61,685 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
Director |
– • – |
2021-10-01 |
4 |
D |
$2.06 |
$36,592 |
D/D |
(17,763) |
64,258 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-03-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
66,730 |
66,730 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2021-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
41,615 |
69,630 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP & Chief Medical Officer |
• – – |
2012-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,208 |
71,403 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP and Chief Medical Officer |
• – – |
2014-11-19 |
4 |
S |
$12.05 |
$301,238 |
D/D |
(24,999) |
74,299 |
0 |
- |
|
98 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
